Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Startup Investors in Germany

Last updated: Apr 2024 A list of 50 angel investors and VC funds that invest in Medical startups based in Germany. We rank investors based on the number of investments they made in Medical companies from Germany. We update this investor list every month.

Top 50 Medical Startup Investors in Germany

Investor	Medical Germany investments
HTGF \| High-Tech Gruenderfonds	15
Bayern Kapital	13
KfW	12
MIG Capital	7
Wellington Partners	7
NRW.BANK	7
b2venture (formerly btov Partners)	6
BioMedPartners	6
Calm/Storm Ventures	5
HV Capital	5
Picus Capital	5
Possible Ventures	5
bm-t beteiligungsmanagement thuringen	5
IBB Ventures	5
TGFS - Technologiegründerfonds Sachsen	5
Atlantic Labs	4
Rheingau Founders	4
EQT Life Sciences	4
Brandenburg Kapital	4
seed + speed Ventures	4
DvH Ventures	3
Vorwerk Ventures	3
Verena Pausder	3
Born2Grow	3
Global Asset Fund	3
Vesalius Biocapital Partners	3
BayBG Venture Capital	3
Forbion Capital Partners	3
WestTech Ventures	3
Diana zur Löwen	3
Sparkasse Jena	3
Feliks Eyser	3
Playground Global	3
Boehringer Ingelheim Venture Fund	3
Gloria Baeuerlein	3
Maximilian Tayenthal	3
Global Life Science Ventures	2
Techno Venture Management	2
Initiative for Industrial Innovators	2
N&V Capital	2
KHAN Technology Transfer Fund	2
Green Park & Golf Ventures	2
Mario Götze	2
Bertelsmann Investments	2
Dagmar Wöhrl	2
HBM Healthcare Investments AG	2
Sunstone Life Science Ventures	2
LSP BioVentures	2
LifeCare Partners	2
Asabys Partners	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.

Investment focus

Software, Information Technology, Biotechnology
Seed, Series A, Funding Round
Germany, Switzerland, United States

Portfolio highlights

Graswald — Graswald engages in the creation of natural and digital 3D worlds for the entertainment industry.
CustomSurg — RETHINKING TRAUMA SURGERY At CustomSurg we are changing the treatment of complex bone fractures from a subjective to an objective approach, through personalized solutions.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.

Investment focus

Software, Health Care, Information Technology
Seed, Series A, Funding Round
Germany, United States, Finland

Portfolio highlights

VITAS — Our system is based on Deep Learning and offers an intelligent voice assistant for customer service. Use cases can be found in both the SME and enterprise market for all companies with many standardized customer calls. VITAS answers the telephone, checks data in real time, can react flexibly to requests and offers the caller a self-service withoutwaiting time. Areas of application include restaurants, workshops, medical practices, taxi centres, insurance companies, banks and tax consultants.
BOX ID Systems — BOX ID Systems develops and offers an end-to-end location & process mining solution to cost effectively track millions of logistics assets digitally throughout the industrial supply chain across Europe and the World - including site-to-site, on-premises and indoor buildings digital twin of supply chain processes. The system is built on aspecialized analytics software platform, sensorik tracking devices and efficient data-, device- and user-management tools, including functions to support process automation and optimization. Industrial and automotive production customers benefit from making their logistics processes more efficient and cost optimized, with 100% transparency within their critical processes throughout the entire supply chain.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the LÃ¤nder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Series A, Series B
Germany, India, Kenya

Portfolio highlights

Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Funding Round, Series B
Germany, Austria, Canada

Portfolio highlights

AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
Look Up Space — Lookup space is the next global leader for space safety, security and sustainability

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Funding Round
Germany, United States, United Kingdom

Portfolio highlights

Nosto — Smarter commerce experience management with AI-fueled personalization, merchandising, and site search
Minervax — MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein : click to read more
Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.

NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.

Investment focus

Biotechnology, Software, Information Technology
Seed, Series A, Series B
Germany, United States

Portfolio highlights

widu — widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace
bNear — bNear is the digital space for all distributed- & hybrid teams - Safe and convenient in Microsoft Teams!
Companyon Analytics — Companyon Analytics provides data security, cloud infrastructure, information technology, technical solutions, and consultancy services.

B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.

Investment focus

Software, Health Care, Information Technology
Series A, Seed, Series B
Germany, Switzerland, United Kingdom

Portfolio highlights

Yendou — We make it unbelievably easy, for clinical operations teams, to manage site selection activities for oncology clinical trials.
DUDE CHEM — DUDE CHEM is a leading company in green chemical manufacturing based in Berlin.
Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Switzerland, Germany, France

Portfolio highlights

Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.

Investment focus

Health Care, Wellness, Medical
Seed, Pre-Seed, Series A
United Kingdom, Germany, Austria

Portfolio highlights

Halm — Halm is building a modern outdoor homecare brand for consumers.
ThinkSono — ThinkSono is a company at the cutting edge of medicine and technology.
Foundation Health — Foundation Health is a telehealth and nationwide pharmacies and diagnostic distribution centre

We support exceptional founders in building market leading digital companies.

Investment focus

E-Commerce, Internet, Software
Series A, Seed, Series B
Germany, United Kingdom, United States

Portfolio highlights

Midas — U.S. Treasuries, On-chain.
Rabot Charge — Rabot Charge offers intelligent charging management solutions for customers to charge their electric cars at home.
Bitlight Labs — Bitlight Labs builds infrastructure using the RGB protocol and the Bitcoin Lightning Network.

Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.

Investment focus

Financial Services, FinTech, Software
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Aleph — Aleph helps top finance teams work with their data in real time. Businesses can automate financial models and streamline budgeting and forecasting with the fastest-to-implement FP&A platform. Aleph eliminates the need to export data from multiple sources by syncing spreadsheet models with data from 150+ integrations, and allows teams tointeract with their data in no-code dashboards.From annual budgeting to ad hoc reporting, scale your financial processes faster with better data without expanding your team. See why over 90% of people who start a trial with Aleph become customers!
Niko Energy — Niko is a Mexico-based provider of residential solar electricity and solar power services for homeowners. It is the first solar company in the country offering rent-to-own financing products on top leasing and cash payments. Fully focused on customer experience, Niko provides a 5-star journey owning each step of the value chain in-house, ensuringquality, security and peace of mind for its customers.
Flawless — Use Flawless to real-time monitor your operational data and quickly identify & resolve incidents. Start in just 5 minutes, no coding required.

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Investment focus

Software, Information Technology, Biotechnology
Seed, Pre-Seed, Series A
Germany, Australia, United States

Portfolio highlights

Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
Zafrens — Zafrens specializes in developing tools and generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States.
Cosmic Aerospace — Cosmic Aerospace is a pioneering aerospace technology company dedicated to advancing the boundaries of propulsion systems and enabling innovative solutions for space exploration. The company collaborates with leading space agencies, research institutions, and commercial partners to design, test, and implement these groundbreaking technologies.

bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
Germany, United States

Portfolio highlights

rooom.com — rooom is a global startup based in Germany, launched in 2019. The company’s experienceCloud is an all-in-one platform for creating, managing and promoting engaging 2D, 3D, AR & VR experiences. It works across all desktop and mobile devices. rooom’s experienceCloud is designed to cover the marketing and visualization needs of differentindustries through their comprehensive product portfolio. These include eventCloud (optimized for virtual events, exhibitions, conferences, meetings), spaceCloud (real estate, property, museums), productCloud (3D products, product showrooms) and immerseCloud (tours, guides, 3D books). rooom’s eventCloud is routinely hosting up to 200,000 users for hybrid events like IFA, Berlin and for global customers such as Porsche, Deutsche Telekom, DHL and E.ON. rooom has won over 20 awards, including the Global Eventex Award (twice), the Innovation & Excellence Award and the German Innovation Award.
tediro — tediro develops a mobile robotics platform for multiple applications in healthcare primarily therapy and diagnostics
Coachwhisperer — Coachwhisperer offers smart intercom and monitoring system for coaches and athletes.

IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.

Investment focus

Software, Health Care, Internet
Seed, Funding Round, Series A
Germany, United States, United Kingdom

Portfolio highlights

Quantistry — Move beyond traditional chemical simulation software and boost your R&D success. From Quantum to AI. Get started!
Meloon — Meloon captures and converts carbon dioxide from the atmosphere.
Elucid Social — Elucid Social integrates businesses with the social good movement through a data-driven strategy that yields measurable results. Elucid Social develops and deploys technologies to assess, report, and minimize human rights risks linked with the sourcing of products and services.

TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.

Investment focus

Software, Information Technology, Manufacturing
Seed, Funding Round, Series A
Germany, United States

Portfolio highlights

MiViA — From microstructure segmentation to grain size measurement! Our AI engine provides a fast and reliable metallographic analysis for metallic products.}
watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
volytica diagnostics — Our software enables customers to develop more economical battery systems, reduce operational risks and establish second-use concepts.

Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.

Investment focus

Health Care, Software, Information Technology
Seed, Pre-Seed, Series A
Germany, Switzerland, United States

Portfolio highlights

Embea — Embea takes Embedded Insurance to Life & Health. Our easy-to-understand plans protect families against the most severe life risks of critical illnesses, accidents, and death. Companies of every size embed our simple and transparent insurance products into their apps and services. Embea removes complexity, paperwork, and pushy sales from theworld of life insurance. Our vision is a world where fair and affordable insurance is accessible to everyone.
Purpose Green — Purpose Green operates as a climatetech company.
150 Minuten — Das Startup 150Minuten aus Berlin möchte Menschen aller Alters- und Fitnessklassen für mehr Sport und Bewegung begeistern. Wir bieten ein modernes, interaktives Online-Kursangebot, an dem jede*r (direkt und live) von Zuhause aus teilnehmen kann.

Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.

Investment focus

Software, E-Commerce, Health Care
Seed, Series A, Pre-Seed
Germany, United States, Poland

Portfolio highlights

NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
Akhetonics — Creating the first all-optical RISC Processor

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).

Investment focus

Software, Health Care, Information Technology
Seed, Series A, Funding Round
Germany, United Kingdom

Portfolio highlights

Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
IQONIC.AI — Creating AI Solutions for Skin, Hair & Inner Balance
Doctorflix — Doctorflix is a medical education platform that allows doctors around the globe to learn about methods of treatment while accelerating their system-required professional development. We are on a mission to build an engine that simplifies and democratizes the consumption and exchange of medical knowledge by interlinking doctors, hospitals, andpharmaceutical companies.

Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.

Investment focus

Software, SaaS, Health Care
Seed, Pre-Seed, Series A
Germany, Austria, Switzerland

Portfolio highlights

happyhotel — The happyhotel revenue and yield management system has a simple dashboard that supports the hotelier in the data analysis of the most important hotel KPI’s. happyhotel is a cloud-based hotel software specially designed for small and medium-sized hotels. Hoteliers can achieve more revenue without a great deal of prior knowledge. The hotelier getpast, current and future values of RevPar, Occupancy, ADR and Revenue. Through the booking pace graph and the on the books evaluation the hotelier can react to the current market conditions. Furthermore the hotelier can review every day the important reports and get an alert if the values do not correspond with the budget. happyhotel use a special formula and an algorithm who gives the hotelier the best price recommendation for his hotel or each of your hotel segments and room types. With an interface to the hotel pms happyhotel get all data to analyze the hotel. happyhotel facilitates the hotelier's life through automatic processes so that he can concentrate on other things.
Helio — Carbon Aware Cloud Computing.
Tokenize.it — Tokenize.it are developing non-custodial token-based fundraising methods.

Investing early in Europe's most passionate founders.

Investment focus

Financial Services, Health Care, FinTech
Seed, Series A, Funding Round
Germany, Austria, United Kingdom

Portfolio highlights

OneTwenty — OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes.
Dr. Vivien Karl — Dr. Vivien Karl relies on a cream for moisturizing care against vulva dryness.
Broken String Biosciences — Our platform accelerates the characterisation of novel gene editing technologies to unlock the next wave of cell & gene therapies.

Vorwerk Ventures is an independent €150m Venture Capital Fund grown out of the Vorwerk Group in late 2019 and defines itself through a strong commitment towards consumer-facing digital businesses. Our unique direct selling experience in addition to an outstanding track record in Venture Capital provides added value for forward-thinkingentrepreneurs. Headquartered in Berlin Germany, we currently have more than €250m in assets under management and are constantly on the look-out for promising opportunities starting with Seed/Series A investments of €1m to €10m and ensuring continuous support reserving up to €15m for upcoming financing rounds. An outstanding founding team, an existing market presence and a well-defined exit strategy framed by a consumer-centric business model are key requirements to us when it comes to making an investment decision.

Investment focus

E-Commerce, Health Care, Food and Beverage
Series A, Seed, Series B
Germany, United Kingdom, United States

Portfolio highlights

Sunhero — Sunhero delivers custom-built solar panel solutions. Sunhero offers consumers a hassle-free method of installing customised photovoltaic solar systems on their homes, be that either purchasing outright or renting for a 20 year period.
CarbonPool — Innovative carbon credit insurance which pays claims in carbon credits, not cash. See how we can help you.
Sorella Care — Sorella is the first network of multidisciplinary health places for women. Sorella ensures that every woman, regardless of age, has access to a comprehensive care pathway offered by women's health specialists.

Verena Pausder

Investment focus

Food and Beverage, E-Learning, Food Delivery
Seed, Pre-Seed, Series A
Germany, United States

Portfolio highlights

Prematch — Prematch leverages AI/NLP technology to automate content aggregation and curation for all non-professional football players in Germany. As a second step, Prematch uses its holistic data silo to create pro-level interaction and gamification experiences for the non-pro ecosystem.
cleverly.de — cleverly.de is an onlineplatform which provides online coaching and tutorial classes.
Tomorrow University of Applied Sciences — Build the skills, competencies, and mindset needed in the 21st-century with our fully-remote and flexible bachelor's and master's degrees.

Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries

Investment focus

Software, Health Care, Medical Device
Seed, Series A, Series B
Germany, United States

Portfolio highlights

Semorai — Semorai - Intelligent error management for manufacturers We are reinventing the future of quality and error control in the industrial industry with our unique AI-as-a-Service solution.
Doinstruct — Doinstruct offers mobile training solution for frontline workers.
traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.

Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.

Investment focus

Medical, Therapeutics, Biotechnology
Series A, Series B, Funding Round
Germany

Portfolio highlights

Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
Belgium, Germany, The Netherlands

Portfolio highlights

CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
Scenic Biotech — We are pioneers in the discovery of genetic modifiers to enable the development of transformative therapeutics.
Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.

Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Series B
Germany, Italy, United States

Portfolio highlights

memtime — memtime shows you everything you worked on during the day. Each program is recorded so that you can quickly remember. Add-on available for any software. | memtime
SUSHI Bikes — SUSHI Bikes has developed the perfect e-bike for modern urban people.
Kloster Kitchen — Kloster Kitchen is a monastery kitchen as the root of unique taste.

Impacting the future of medicine.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, United Kingdom, The Netherlands

Portfolio highlights

Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
Calluna Pharma — Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.
Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.

WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.

Investment focus

Software, Internet, Information Technology
Seed, Series A, Funding Round
Germany, United States, France

Portfolio highlights

Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
THE CLIMATE CHOICE — The software platform for decarbonizing companies and their supply chains.

Diana zur Löwen

Investment focus

Financial Services, Software, EdTech
Pre-Seed, Seed, Debt Financing
Germany, Switzerland

Portfolio highlights

Nelly — Nelly provides tool for medical practices that simplifies patient onboarding and payments.
Junto — Elevate your business performance with impactful leadership training. Junto's leadership development programs equip your people with the skills and behaviours to thrive.
Calvin Risk — We help companies manage the risks of their AI algorithms!

Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.

Investment focus

Medical, Shopping, E-Commerce
Seed, Series A, Series C
Germany, United States

Portfolio highlights

ShopCo Technologies — Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib.
NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
Dynamic42 — Dynamic42 provides, customizes innovative 3D microphysiological in vitro test systems recreating human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for preclinical research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems.

Feliks Eyser is the founding partner of JETPACK.

Investment focus

Software, E-Learning, Internet
Seed, Series A, Funding Round
Germany

Portfolio highlights

Junto — Elevate your business performance with impactful leadership training. Junto's leadership development programs equip your people with the skills and behaviours to thrive.
cleverly.de — cleverly.de is an onlineplatform which provides online coaching and tutorial classes.
ExpressSteuer — ExpressSteuer is building AI-powered software that simplifies and automates the process of filing a german tax return which is considered to be the most complex and complicated in the world.

Playground is an early-stage investment firm that helps old and new investors and entrepreneurs working at the intersection of bits, atoms, and AI. It focuses on investment, innovation, connected hardware, artificial intelligence, and robotics.

Investment focus

Software, Robotics, Artificial Intelligence
Series A, Seed, Series B
United States, Canada, France

Portfolio highlights

Boxbot — Dynamic storage and retrieval platform that adapts to varying cubic dimensions and eliminates manual pick stations.
Insamo — Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
Element Zero — Element Zero - The Green Metal Company. Element Zero has developed a novel approach to cost-effectively and efficiently convert metal ores such as iron ore, nickel ore and other future facing metals, to pure metal form with zero carbon emissions.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.

Gloria primarily focuses on growth stage investments across all sectors in Europe and Australia. Prior to Index, Gloria worked at Technology Crossover Ventures, a Silicon Valley-based growth equity fund, evaluating investment opportunities in the DACH region and in software and fintech companies across Europe. Gloria started her career at MorganStanley where she advised technology and telco clients across Europe and the U.S. on financing rounds, IPOs and M&A transactions. Gloria graduated with a master’s degree in management from WHU – Otto Beisheim School of Management

Investment focus

B2B, Apps, SaaS
Pre-Seed, Seed, Series A
Germany, Sweden, Denmark

Portfolio highlights

Pile — Pile is a cryptocurrency as a service platform for fintechs and neobanks. Founded in 2022 and is based in Berlin, Berlin, Germany.
Procuros — More and more sales teams struggle with supplier portals. We help you integrate digitally with common supplier portals and consolidate all order documents.
PocketLaw — PocketLaw is a user-friendly and affordable solution that allows you to create contracts, get legal guidance, manage your documents and contact lawyers.

Maximilian Tayenthal is co-founder and co-CEO of N26. Together with his business partner and friend Valentin Stalf, he built one of the first and now fastest-growing mobile banks in Europe. Their vision was to create a retail bank that's flexible, transparent and speaks to today's digital lifestyles. Previously, Max worked in a varietyof consulting and financial roles at leading professional services firms, including CMS and Booz & Company. Max holds bachelor’s and master’s degrees in economics and business administration from the University of Vienna. He also has a master’s degree in economics from the Community of European Management Schools, as well as a law degree form the University of Vienna. Max is a CFA charterholder. While Max is based in Berlin, he always makes time for his passion outside of personal finance: skiing in the mountains of Austria and Switzerland.

Investment focus

FinTech, Financial Services, Information Technology
Seed, Pre-Seed, Series A
Germany, United Kingdom, France

Portfolio highlights

Vitt — Vitt is building a platform that simplifies both fundraising for SaaS founders and creates a new asset class for investors to invest in. A SaaS company that has contracted revenue can apply for financing it upfront — rather than waiting for cash to come in monthly, through Vitt's web application they get the cash upfront.Vitt analyses theirfinancial data and gives them a financing decision in a matter of minutes — not months. No more searching for intros to venture capitalists in your network. It shouldn't be about who you know but what you've built.
Soveren — Soveren helps engineering and security teams protect personal data by detecting privacy risks and analyzing real-time data flows within your infrastructure.
beatvest — An investment platform supporting do-it-yourself portfolio building with education and tools

Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance,advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.

Investment focus

Biotechnology, Health Care, Medical
Series C, Series A, Series B
United States, Germany, Denmark

Portfolio highlights

Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
Coapt Systems — Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilizationtrays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.
Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).

Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, Germany, United Kingdom

Portfolio highlights

Streaming21 — Checkout the full domain details of Streaming21.com. Click Buy Now to instantly start the transaction or Make an offer to the seller!
Revolt Technology — News & Informations
Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.

Initiative for Industrial Innovators aim at funding up to 2,000 disruptive deep tech solutions until 2024 through our fast funding instruments. The Initiative for Industrial Innovators enables local ecosystems, each consisting of a local multi-generational Family Office, a local innovation center, and a local technical university, to join forces.

Investment focus

Software, Medical, Health Care
Seed, Pre-Seed, Series A
Germany

Portfolio highlights

OCELL — Building the Operating System of Sustainable Forestry
Filics — A scalable transport solution for standardized load carriers with a minimum energy footprint
FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.

N & V Capital is a family-owned venture capital boutique focused on European investments. With generations of entrepreneurial experience, we seek scalable ventures driven by technology or scientific progress. We engage primarily up to Series A rounds, preferring early-stage involvement to support visionary founders aiming for sustainablegrowth. Our commitment is for the long term, and we are driven by pragmatism, open-mindedness, and hands-on assistance wherever required.

Investment focus

Health Care, Leasing, Medical
Seed, Pre-Seed, Series A
Germany, Switzerland

Portfolio highlights

LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
Likeminded — Likeminded developed a digital platform for mental health that gives people fast, low-threshold access to psychological support.
Virtonomy GmbH — Virtonomy is shortening time-to-market of medical products by conducting data driven studies on virtual patients.

KHAN Technology Transfer Fund operates as an investment firm.

Investment focus

Medical, Therapeutics, Biotechnology
Seed, Series A
Germany, Czech Republic, United Kingdom

Portfolio highlights

Nodus Oncology — Nodus Oncology Developing the DDR targeting therapies.
Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
Qli5 Therapeutics — Qli5 Therapeutics develops a new class of proteasome inhibitors with high selectivity and unique, non-covalent binding properties.

Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
United States, Israel, Sweden

Portfolio highlights

Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.

Mario Götze is a professional footballer.

Investment focus

Software, Information Technology, SaaS
Seed, Pre-Seed, Series A
Germany, United States, United Kingdom

Portfolio highlights

Unaric — Our mission is to help Salesforce customers maximise their investment on the Salesforce platform through an integrated suite of applications. Explore our application suites across Revenue Operations, Service Operations and System Administration.
Metergrid — Metergrid is a developer of SaaS products for specific problems in decentralized energy systems. They offer a market-leading automated cloud solution for the profitable realization, management, and billing of tenant power projects and charging infrastructure.
LANCH — LANCH is a startup that provides a virtual kitchen and food delivery service.

The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.

Investment focus

Health Care, Medical, Artificial Intelligence
Series B, Series A, Seed
Germany, Malaysia, Singapore

Portfolio highlights

Patient 21 — Patient21 believes that the doctor-patient connection is the cornerstone to good healthcare and that it is their responsibility to remove any impediments to it. They think that the greatest healthcare necessitates cross-specialty collaboration and universal data access. Always with one purpose in mind: to help patients and physicians make betterdecisions.In comparison to today's linked world, healthcare appears to be trapped in the past. It continues to use the same analogue and isolated processes. Patient21 is on a quest to usher healthcare into the twenty-first century. They use data to help doctors give the most personalized treatments possible. And, with the help of their professional network, they are attempting to give a comprehensive perspective of their client's health.
Phare Health — Phare Health transforms the back office of healthcare, making it more efficient, accurate, and resillient.
QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.

Dagmar Wöhrl

Investment focus

Food and Beverage, SaaS, Sustainability
Angel, Seed, Funding Round
Germany, United States

Portfolio highlights

Häppysnäx — The HPPYSNX philosophy is as simple as it is ingenious: less sugar for a better taste experience and more pleasure when snacking. Because of food production methods that have been passed down through generations.
Interior Circle — The interior circle benefit living in one every day and wanting to improve it. Others may appreciate a water supply, but we are pleased with the new vase. What if we could make only one small change while still experiencing wonderful new things This is exactly what we want to accomplish with our company! alongside youWe specifically give up ourcommission for this purpose. We utilize this money to provide housing—their own homes or other important social structures—to those living in nations with inadequate social infrastructure. Our program will not be able to alter the course of history. However, we also want to create our own business.
Mary Kwong — Mary Kwong relies on Peking duck in the cooking box.

As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures' portfolio companies are either at an advanced stage of development or already available on the market. The companyfocuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).

Investment focus

Biotechnology, Health Care, Medical
Series B, Series C, Series A
United States, Switzerland, China

Portfolio highlights

Upstream Bio — Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. Upstream Bio was founded in 2004 and was headquartered in the United States.
Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Odyssey Therapeutics — Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for patients with cancer inflammatory diseases

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Investment focus

Biotechnology, Health Care, Medical
Funding Round, Series B, Series A
Denmark, Sweden, Switzerland

Portfolio highlights

Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.

LSP BioVentures is a venture capital fund focused on opportunities in the life science arena. Based in Cambridge (MA) in the USA; the fundâ€™s management combines the strength of its parent company, Life Sciences Partners Venture Capital firm in Europe and a dedicated team of experts in the USA.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Germany, United Kingdom

Portfolio highlights

Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.

LifeCare Partners provides private equity and mezzanine financing

Investment focus

Biotechnology, Medical, Health Care
Series A, Funding Round, Post-IPO Equity
Germany, Switzerland, United States

Portfolio highlights

b-rayZ — Optimize and streamline your breast imaging workflow with AI excellence and precision from b-rayZ. Your trusted partner in breast diagnostics.
Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
NeoPrediX — NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize intelligent algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists,pediatricians, and neonatologists. We transform medical data into intelligent predictions to support clinical decisions.

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Seed, Series B
Spain, Belgium, Germany

Portfolio highlights

Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate